Top Cost-Containment Stories
Prescription drug pricing tackled by asset manager, interfaith group
By Marlene Y. SatterAzzad Asset Management, advisor to the Azzad Funds, along with other members of the Interfaith Center on Corporate Responsibility have filed resolutions this year with 11 major U.S. pharmaceutical companies advocating reassessment of pricing policy.
